SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for controlled trials of drugs in migraine. 2nd ed. Cephalalgia. 2000;20: 765-778.
  • 2
    Schoenen J, Boureau F, Kunkel R, et al. Guidelines for trials of drug treatments in tension-type headache. 1st ed. Cephalalgia. 1995;15: 165-179.
  • 3
    Lipton RB, Micieli G, Russell D, et al. Guidelines for controlled trials in cluster headache. 1st ed. Cephalalgia. 1995;15: 452-461.
  • 4
    Penzien DB, Rains JC, Lipchik GL, Nicholson RA, Lake AE, Hursey KG. Future directions in behavioral headache research: applications for an evolving healthcare environment. Headache. 2005;45: 526-534.
  • 5
    Ethics Subcommittee of the International Headache Society. Ethical issues in headache research and management. Cephalalgia. 1998;18: 505-529.
  • 6
    Altman DG, Schulz KF, Moher D, et al, for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Int Med. 2001;134: 663-694.
  • 7
    Davidson KW, Goldstein M, Kaplan RM, et al Evidence-based behavioral medicine: what is it and how do we achieve it? Ann Behav Med. 2003;26: 161-171.DOI: 10.1207/S15324796ABM2603_01
  • 8
    Penzien DB. Headache research methodology: introduction to the special series. Headache. 2005;45: 408-410.
  • 9
    Maizels M. Why should physicians care about behavioral research? Headache. 2005;45: 411-413.
  • 10
    Houle TT, Penzien DB, Houle CK. Statistical power and sample size estimation for headache research: an overview and power calculation tools. Headache. 2005;45: 414-418.
  • 11
    Lipchik GL, Nicholson RA, Penzien DB. Allocation of patients to conditions in headache clinical trials: randomization, stratification, and treatment matching. Headache. 2005;45: 419-428.
  • 12
    Andrasik F, Lipchik GL, McCrory DC, Wittrock DA. Outcome measurement in headache research: headache parameters and psychosocial outcomes. Headache. 2005;45: 429-437.
  • 13
    Houle TT, Remble TA, Houle TA. The examination of headache activity using time-series research designs. Headache. 2005;45: 438-444.
  • 14
    Houle TT, Penzien DB, Rains JC. Time-series features of headache: individual distributions, patterns, and predictability of pain. Headache. 2005;45: 445-458.
  • 15
    McCrory DC, Rebecca N, Gray RN, Tfelt-Hansen P, Steiner TJ, Taylor FR. Methodological issues in systematic reviews of headache trials: adapting historical diagnostic classifications and outcome measures to present-day standards. Headache. 2005;45: 459-465.
  • 16
    Hursey KG, Rains JC, Penzien DB, Nash JM, Nicholson RA. Behavioral headache research: methodologic considerations and research design alternatives. Headache. 2005;45: 466-478.
  • 17
    Rains JC, Penzien DB. Behavioral research and the double-blind placebo-controlled methodology: challenges in applying the biomedical standard to behavioral headache research. Headache. 2005;45: 479-486.
  • 18
    Holroyd KA, Powers SW, Andrasik F. Methodological issues in clinical trials of drug and behavior therapies. Headache. 2005;45: 493-506.
  • 19
    Lake AE III, Rains JC, Penzien DB, Lipchik GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache. 2005;45: 493-506.
  • 20
    Nash JM, McCrory DC, Nicholson RA, Andrasik F. Efficacy and effectiveness approaches in behavioral treatment trials. Headache. 2005;45: 507-512.
  • 21
    Nicholson RA, Hursey KG, Nash JM. Moderators and mediators of behavioral intervention for headache. Headache. 2005;45: 513-519.
  • 22
    Andrasik F, Powers SW, McGrath PJ. Methodological considerations in research with special populations: children and adolescents. Headache. 2005;45: 520-525.
  • 23
    Lipton RB, Bigal ME. Editorial. Headache. 2005;45: 535-537.
  • 24
    Penzien DB, Rains JC, McGrath PJ. Psychological and behavioral treatments for migraine. In: OlesenJ, GoadsbyP, RamadanN, Tfelt-HansenP, WelchKMA, eds. The Headaches, 3rd ed. Philadelphia : Lippincott, Williams, and Wilkins; in press.
  • 25
    Rains JC, Penzien DB, McCrory DC, Gray RN. Behavioral headache treatment: history, review of the empirical literature and methodology. Headache. 2005;45(suppl 2): S92-S109.
  • 26
    Bernstein DA, Borkovec TD. Progressive Relaxation Training: A Manual for the Helping Professions. Champaign , IL : Research Press; 1973.
  • 27
    Bernstein DA, Borkovec TD, Hazlett-Stevens H. New Directions in Progressive Relaxation Training: A Guidebook for Helping Professionals. Westport , CT : Praeger Publishers; 2000.
  • 28
    Jacobson E. Progressive Relaxation: A Physiological and Clinical Investigation of Muscular States and their Significance in Psychology and Medical Practice. Chicago : University of Chicago Press; 1929.
  • 29
    Jacobson E. Progressive Relaxation. Chicago : University of Chicago Press; 1934.
  • 30
    Schultz J, Luthe W. Autogenic Training: A Psychophysiologic Approach to Psychotherapy, Vol. 1. New York : Grune & Stratton; 1959.
  • 31
    Benson H. The Relaxation Response. New York : William Morrow & Co; 1975.
  • 32
    Holroyd KA, Penzien DB, Lipchik GL. Behavioral management of headache. In: SilbersteinSD, LiptonRB, DalessioDJ, eds. Wolff's Headache and Other Head Pain, 7th ed. New York : Oxford University Press. 2001: 562-598.
  • 33
    SchwartzMS, AndrasikF (eds.). Biofeedback: A Practitioner's Guide, 3rd ed. New York : Guilford Press; 2003.
  • 34
    Holroyd KA, Andrasik F. A cognitive-behavioral approach to recurrent tension and migraine headache. In: KendallPE, ed. Advances in Cognitive-Behavioral Research and Therapy. New York : Academic Press; 1982.
  • 35
    Holroyd KA, Appel M, Andrasik F. A cognitive-behavioral approach to the treatment of psychophysiological disorders. In: MeichenbaumD, JaremkoM, eds. Stress Prevention and Management: A Cognitive-Behavioral Approach. New York : Plenum Press; 1982: 219-257.
  • 36
    Holroyd KA, Holm JE, Penzien DB. Clinical issues in the behavioral treatment of recurrent headache. In: KellerPA, HeymanSR, eds. Innovations in Clinical Practice: A Source Book, Vol. 7. Sarasota , FL : Professional Resource Exchange ; 1988: 433-457.
  • 37
    Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders (2nd Ed.). Cephalalgia. 2004;24(suppl 1):1-160.
  • 38
    Silberstein SD, Lipton RB, Solomon S, Mathew NT. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994;34: 1-7.DOI: 10.1111/j.1526-4610.1994.hed3401001.x
  • 39
    Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41: 646-657.DOI: 10.1046/j.1526-4610.2001.041007646.x
  • 40
    Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58: 885-894.
  • 41
    Rains JC, Penzien DB, Martin V. Migraine and women's health. J Am Med Womens Assoc. 2002;57: 73-78.
  • 42
    Silberstein SD. Hormone-related headache [Review]. Med Clin N Am. 2001;85: 1017-1035.
  • 43
    Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD. Menstrual cycle and headache in a population sample of migraineurs [Review]. Neurology. 2000;55: 1517-1523.
  • 44
    Silberstein SD. Sex hormones and headache [Review]. Rev Neurol (Paris). 2000;156(suppl 4):4S30-4S41.
  • 45
    Silberstein SD. Shared mechanisms and comorbidities in neurologic and psychiatric disorders [Review]. Headache. 2001;41(suppl 1):S11-S17.DOI: 10.1046/j.1526-4610.2001.01154-3.x
  • 46
    Lipchik GL, Penzien DB. Psychiatric comorbities in patients with headache. In: BackonjaHM, ed. Seminars in Pain Medicine: Headache. 2004;2: 93-105.
  • 47
    Penzien DB, Peatfield RC, Lipchik GL. Headache in patients with co-morbid psychiatric disease. In: OlesenJ, GoadsbyP, RamadanN, Tfelt-HansenP, WelchKMA, eds. The Headaches, 3rd ed. Philadelphia : Lippincott, Williams, and Wilkins; in press.
  • 48
    Breslau N. Psychiatric comorbidity in migraine. Cephalalgia. 1998;18 (suppl 22):56-58.
  • 49
    Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology. 2000;54: 308-313.
  • 50
    Breslau N, Schultz LR, Stewart WF, Lipton R, Welch KM. Headache types and panic disorder: directionality and specificity. Neurology. 2001;56: 350-354.
  • 51
    Puca F, Genco S, Prudenzano MP, et al. Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. Cephalalgia. 1999;159-164.
  • 52
    Saper JR, Lake AE III. Borderline personality disorder and the chronic headache patient: review and management recommendations [Review]. Headache. 2002;42: 663-674.DOI: 10.1046/j.1526-4610.2002.02156.x
  • 53
    Sheftell FD, Atlas SJ. Migraine and psychiatric comorbidity: from theory and hypotheses to clinical application. Headache. 2002;42: 934-944.DOI: 10.1046/j.1526-4610.2002.02217.x
  • 54
    Silberstein SD, Lipton RB, Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia. 1995;15: 337-369.
  • 55
    Penzien DB, Rains JC, Holroyd KA. Psychological assessment of the recurrent headache sufferer. In: TollisonCD, KunkelRS, eds. Headache: Diagnosis and Treatment. Baltimore : Williams and Wilkins. 1993: 39-49.
  • 56
    Guidetti V, Galli F, Fabrizi P, et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia. 1998;18: 455-462.
  • 57
    Hersen M, Barlow DH. Single Case Experimental Designs: Strategies for Studying Behavior Change (Pergamon General Psychology Series, No. 56). New York : Pergamon Press; 1992.
  • 58
    Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chron Dis. 1967;20: 637-648.DOI: 10.1016/0021-9681(67)90041-0
  • 59
    Klein DF. Control groups in pharmacotherapy and psychotherapy evaluations. Available at: http://journals.apa.org/prevention. Accessed September 27, 2004.
  • 60
    Borkovec TD, Onken LS. Recommendations for research concerning the use of placebos in clinical trials to test behavioral interventions. In: GuessHA, KleinmanA, KusekJW, EngelLW, eds. The Science of Placebo: Toward an Interdisciplinary Research Agenda. London : BMJ Books; 2002: 306-310.
  • 61
    World Medical Assembly Declaration of Helsinki: Recommendations guiding medical doctors in biomedical research involving human subjects. Helsinki, Finland: 18th WMA, 1964. Revised Tokyo, Japan: 29th WMA, 1975; Venice, Italy: 35th WMA, 1983; Hong Kong: 41st WMA, 1989; Somerset West, South Africa: 48th WMA, 1996; Edinburgh, Scotland: 52nd WMA, 2000. Available at: http://www.wma.net/e/ethicsunit/helsinki.htm. Accessed on November 1, 2004.
  • 62
    World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med. 2002;48: 206-208.
  • 63
    Levine RJ. Placebo controls in clinical trials of new therapies for conditions for which there are know effective treatments. In: GuessHA, KleinmanA, KusekJW, EngelLW, eds. The Science of the Placebo: Toward an interdisciplinary research agenda. London : BMJ Books; 2002: 264-280.
  • 64
    Linde M, May A, Limmroth V, Dahlof C, on behalf of the Headache Masters Programme. Ethical aspects of placebo in migraine research. Cephalalgia. 2003;23: 491-495.
  • 65
    Pocock SJ. The pros and cons of non-inferiority (equivalence) trials. In: GuessHA, KleinmanA, KusekJW, EngelLW, eds. The Science of Placebo: Toward an Interdisciplinary Research Agenda. London : BMJ Books; 2002: 236-248.
  • 66
    Pocock SJ. The pros and cons of noninferiority trials. Fundam Clin Pharmacol. 2003;17: 483-490.DOI: 10.1046/j.1472-8206.2003.00162.x
  • 67
    Temple RJ. Placebo controlled trials and active controlled trials: ethics and inference. In: EngelLW, ed. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London : BMJ Books; 2002: 209-226.
  • 68
    Blanchard EB, Appelbaum KA, Radnitz C, Morrill B, Michultka D, Kirsch C, et al. A controlled evaluation of thermal biofeedback and thermal biofeedback combined with cognitive therapy in the treatment of vascular headache. J Consult Clin Psychol. 1990;58: 216-224.DOI: 10.1037//0022-006X.58.2.216
  • 69
    Blanchard EB, Applebaum KA, Radnitz CL, et al. Placebo-controlled evaluation of abbreviated progressive muscle relaxation and of relaxation combined with cognitive therapy in the treatment of tension headache. J Consult Clin Psychol. 1990;58: 210-215.DOI: 10.1037//0022-006X.58.2.210
  • 70
    Blanchard EB, Peters ML, Herman C, Turner SM, Buckley TC, Barton SM. Direction of temperature control in the thermal biofeedback treatment of vascular headache. Appl Psychophysiol Biofeedback. 1997;22: 227-246.
  • 71
    Holroyd KA, Andrasik F, Noble J. A comparison of EMG biofeedback and a credible pseudotherapy in treating tension headache. J Behav Med. 1980;3: 29-39.DOI: 10.1007/BF00844912
  • 72
    Holroyd KA, Penzien DB, Hursey K, et al. Change mechanisms in EMG biofeedback training: cognitive changes underlying improvements in tension headache. J Consult Clin Psychol. 1984;52: 1039-1053.DOI: 10.1037//0022-006X.52.6.1039
  • 73
    Elkin I, Pilkonis PA, Docherty JP, Sotsky SM. Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, I: active ingredients and mechanisms of change. Am J Psychiatry. 1988;145: 909-917.
  • 74
    Elkin I, Pilkonis PA, Docherty JP, Sotsky SM. Conceptual and methodological issues in comparative studies of psychotherapy, II: nature and timing of treatment effects. Am J Psychiatry. 1988;145: 1070-1076.
  • 75
    Holroyd K. Integrating pharmacologic and non-pharmacologic treatments. In: TolisonCD, KunkelRS, eds. Headache Diagnosis and Interdisciplinary Treatment. Baltimore : Williams and Wilkins; 1993: 309-320.
  • 76
    Hollon SD. The relative efficacy of drugs and psychotherapy: methodological considerations. In: WeissmanS, SabshinM, EistH, eds. Psychiatry in the New Millenium. Washington , D.C. : American Psychiatric Press, Inc.; 1999.
  • 77
    Jacobson NS, Hollon SD. Prospects for future comparisons between drugs and psychotherapy: lessons from the CBT-versus-Pharmacotherapy exchange. J Consult Clin Psychol. 1996;64: 104-108.DOI: 10.1037//0022-006X.64.1.104
  • 78
    Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A. A comparison of pharmacological (amitriptyline HCl) and nonpharmacological (cognitive-behavioral) therapies for chronic tension headaches. J Consult Clin Psychol. 1991;59: 387-393.DOI: 10.1037//0022-006X.59.3.387
  • 79
    Klein D. Studying the respective contributions of pharmacotherapy and psychotherapy. In: WeissmanS, SabshinM, EistH, eds. Psychiatry in the New Millenium. Washington , D.C. : American Psychiatric Press, Inc.; 1999.
  • 80
    Klein D. New ideals for testing treatments—what's wrong and how to fix it. In: WeissmanS, SabshinM, EistH, eds. Psychiatry in the New Millenium. Washington , D.C. : American Psychiatric Press, Inc.; 1999.
  • 81
    Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson B. Management of chronic tension-type headache with tricyclic antidepressant medication, stress-management therapy, and their combination: a randomized controlled trial. JAMA. 2001;285: 2208-2215.DOI: 10.1001/jama.285.17.2208
  • 82
    Schwartz CE, Chesney MA, Irvine MJ, Keefe F. The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials. Psychosom Med. 1996;59: 362-371.
  • 83
    Califf RM, Al-Kathib SM. Use of placebos in large-scale pragmatic trials. In: GuessHA, KleinmanA, KusekJW, EngelLW, eds. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London : BMJ Books 2002;249-263.
  • 84
    Feigal DW. Recommendations for research concerning the use of placebos in clinical trials to test pharmacological and procedural interventions. In: GuessHA, KleinmanA, KusekJW, EngelLW, eds. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London : BMJ Books , 2002: 300-305.
  • 85
    Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med. 1994;331: 394-398.DOI: 10.1056/NEJM199408113310611
  • 86
    Rothman KJ, Michels KB. When is it appropriate to use a placebo arm in a trial? In: GuessHA, KleinmanA, KusekJW, EngelLW, eds. The Science of the Placebo: Toward an Interdisciplinary Research Agenda. London : BMJ Books; 2002: 227-235.
  • 87
    Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York : Lawrence Erlbaum Assoc. ; 1988.
  • 88
    Kraemer HC. How Many Subjects? Statistical Power Analysis in Research. Beverly Hills , CA : Sage Publications; 1987.
  • 89
    Pocock SJ. Clinical Trials: A Practical Approach. Chichester : John Wiley & Sons; 1983.
  • 90
    Sorensen PS, Hansen K, Olesen J. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia. 1986;6: 7-14.
  • 91
    Whitlock EP, Orleans CT, Pender N, Allan J. Evaluating primary care behavioral counseling interventions: an evidence-based approach [Review]. Am J Prev Med. 2002;22: 267-284.
  • 92
    Penzien DB, Johnson CA, Seville J, et al. Interrelationships among daily and global self-report measures of headache. Headache Q. 1994;5: 8-14.
  • 93
    Lake AE III, Saper JR. Chronic headache: new advances in treatment strategies. Neurology. 2002;59(5 suppl 2):S8-S13.
  • 94
    Ethical principles of psychologists and code of conduct. Am Psychol. 2002;57: 1060-1073.
  • 95
    National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.htm. Accessed on November 1, 2004.
  • 96
    Langeveld JH, Koot HM, Loonen MC, Hazebroek-Kampschreur AA, Passchier J. A quality of life instrument for adolescents with chronic headache [Discussion 137]. Cephalalgia. 1996;16: 183-196.
  • 97
    Powers SW, Patton SR, Hommel KA, Hershey AD. Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0. Cephalalgia. 2004;24: 120-127.
  • 98
    Hershey AD, Powers SW, Vockell AL, LeCates SL, Segers A, Kabbouche MA. Development of a patient-based grading scale for PedMIDAS. Cephalalgia. 2004;24: 844-849.